
Kushal Agrawal
About Kushal Agrawal
Data last updated:
Kushal Agrawal is a Director at Caventis Pharma Private Limited (since 2013) and Director at Rhizoid Healthcare Private Limited (since 2021). The companies operate in Pharma and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹4.96 Cr; the largest is Caventis Pharma Private Limited at ₹4.88 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 19 Sep 2013 | 2012 | ₹4.88 Cr (FY 2024) | Active | |
| Director | 23 Jun 2021 | 2021 | ₹8.2 Lakh (FY 2024) | Active |
Board colleagues of Kushal Agrawal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ketan Agrawal | 06729861 | Caventis Pharma Private Limited , Rhizoid Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kushal Agrawal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kushal Agrawal
Kushal Agrawal currently holds 2 directorships: Caventis Pharma Private Limited (Director, since 19 Sep 2013, revenue ₹4.88 Cr (FY 2024)); Rhizoid Healthcare Private Limited (Director, since 23 Jun 2021, revenue ₹8.2 Lakh (FY 2024)).
Kushal Agrawal was first appointed on 19 Sep 2013 as Director at Caventis Pharma Private Limited. The most recent appointment on record is 23 Jun 2021 at Rhizoid Healthcare Private Limited.
The 2 current companies of Kushal Agrawal that report revenue have a combined latest revenue of ₹4.96 Cr: Caventis Pharma Private Limited ₹4.88 Cr (FY 2024); Rhizoid Healthcare Private Limited ₹8.2 Lakh (FY 2024).
The current boards of Kushal Agrawal's companies include Ketan Agrawal (Caventis Pharma Private Limited).